Showing results (361-370 of 439) with videos related to

Sort By:
Pageof 44
Lung Cancer (Amsterdam, Netherlands)|July 18, 2025
Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doubletAstrid Paulus, Marius Zemaitis, Saulius Cicenas, et al.
Cancer Research|March 27, 1998
Heparan/chondroitin/dermatan sulfate primer 2-(6-hydroxynaphthyl)-O-beta-D-xylopyranoside preferentially inhibits growth of transformed cellsK Mani, B Havsmark, S Persson, et al.
Acta Neuropathologica Communications|September 15, 2023
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesisYuriy Pomeshchik, Erika Velasquez, Jeovanis Gil, et al.
The American Journal of Pathology|May 1, 2025
Collagen VII Is Associated with Airway Remodeling, Honeycombing, and Fibroblast Foci in Usual Interstitial Pneumonia/Idiopathic Pulmonary FibrosisBarbora Svobodová, Anna Löfdahl, Måns Kadefors, et al.
BMC Psychiatry|August 6, 2022
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten childrenParisa Hajjari, Malin Huldt Oldmark, Elisabeth Fernell, et al.
International Journal of Molecular Sciences|January 9, 2021
Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial MigrationMariam Bagher, Oskar Rosmark, Linda Elowsson Rendin, et al.
Journal of Clinical and Experimental Neuropsychology|January 21, 2026
Trade-off between speed and accuracy: associations between obsessive-compulsive symptoms and meticulousness in PANSHelena Holmäng, Rosanna Fagerudd, Parisa Hajjari, et al.
F1000Research|November 20, 2020
CRI iAtlas: an interactive portal for immuno-oncology researchJames A Eddy, Vésteinn Thorsson, Andrew E Lamb, et al.
British Journal of Cancer|December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumoursDebbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.
Journal of Translational Medicine|August 24, 2012
Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patientsOskar Hallgren, Sara Rolandsson, Annika Andersson-Sjöland, et al.
Pageof 44